Conversely, ER-60 was previously reported as less expressed in GBM relatively to low-grade astrocytomas [32,35], although its key role in the control of newly synthesized glycoproteins during oncogenic transformation has been recently assessed [36]. Here, PDIA3 is linked to glioblastoma.